SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001206774-05-000684
Filing Date
2005-04-22
Accepted
2005-04-22 06:01:55
Documents
5
Period of Report
2005-05-19
Effectiveness Date
2005-04-22

Document Format Files

Seq Description Document Type Size
1 d16829.htm DEF 14A 285242
2 GRAPHIC avantlogo.jpg GRAPHIC 14626
3 GRAPHIC catlinsig.jpg GRAPHIC 21460
4 GRAPHIC d16829line.jpg GRAPHIC 127761
5 GRAPHIC wardsig.jpg GRAPHIC 20809
  Complete submission text file 0001206774-05-000684.txt   541748
Mailing Address 119 FOURTH AVE NEEDHAM MA 021942725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
AVANT IMMUNOTHERAPEUTICS INC (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-15006 | Film No.: 05765913
SIC: 2835 In Vitro & In Vivo Diagnostic Substances